Integrated Technology Improves Blood Transfusion Safety

Neoteric and Mediware's agreement will provide hospitals, clinics, correctional institutions, blood centers, and other public and private healthcare institutions with a closed loop environment for transfusion information to increase patient safety practices, lower costs, and improve efficiencies and productivity of the entire blood transfusion process.

Neoteric's blood management products, which will be marketed by Mediware in North America under the BloodSafe brand name, will extend Mediware's HCLL transfusion management system and enable better control of blood products within the hospital and ensure that blood is transfused to the right patient following the right procedures at the bedside. This will improve the blood banks' ability to manage blood inventory while increasing patient safety.

"More than two-thirds of transfusion errors are a result of activities that occur outside the four walls of the blood bank,” said John Damgaard, chief operations officer of Mediware Information Systems. "By combining Neoteric's revolutionary remote allocation and bedside administration capabilities with HCLL in the blood bank, healthcare providers have a powerful patient safety advantage.”

The HCLL suite of products provides healthcare facilities with powerful technology and rich clinical functionality necessary to streamline blood management processes--from donation to transfusion.


Related Links:
Neoteric Technology
Mediware Information Systems